Competition in the German pharmacy market: an empirical analysis

Pharmaceutical products are an important component of expenditure on public health insurance in the Federal Republic of Germany. For years, German policy makers have regulated public pharmacies in order to limit the increase in costs. One reform has followed another, main objective being to increase...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMC health services research 2013-10, Vol.13 (1), p.407-407, Article 407
Hauptverfasser: Heinsohn, Jörg G, Flessa, Steffen
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 407
container_issue 1
container_start_page 407
container_title BMC health services research
container_volume 13
creator Heinsohn, Jörg G
Flessa, Steffen
description Pharmaceutical products are an important component of expenditure on public health insurance in the Federal Republic of Germany. For years, German policy makers have regulated public pharmacies in order to limit the increase in costs. One reform has followed another, main objective being to increase competition in the pharmacy market. It is generally assumed that an increase in competition would reduce healthcare costs. However, there is a lack of empirical proof of a stronger orientation of German public pharmacies towards competition thus far. This paper analyses the self-perceptions of owners of German public pharmacies and their orientation towards competition in the pharmacy markets. It is based on a cross-sectional survey (N = 289) and distinguishes between successful and less successful pharmacies, the location of the pharmacies (e.g. West German States and East German States) and the gender of the pharmacy owner. The data are analysed descriptively by survey items and employing bivariate and structural equation modelling. The analysis reveals that the majority of owners of public pharmacies in Germany do not currently perceive very strong competitive pressure in the market. However, the innovativeness of the pharmacist is confirmed as most relevant for net revenue development and the profit margin. Some differences occur between regions, e.g. public pharmacies in West Germany have a significantly higher profit margin. This study provides evidence that the German healthcare reforms aimed at increasing the competition between public pharmacies in Germany have not been completely successful. Many owners of public pharmacies disregard instruments of active customer-orientated management (such as customer loyalty or an offensive position and economies of scale), which could give them a competitive advantage. However, it is clear that those pharmacists who strive for systematic and innovative management and adopt an offensive and competitive stance are quite successful. Thus, pharmacists should change their attitude and develop a more professional business model.
doi_str_mv 10.1186/1472-6963-13-407
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3856528</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A534637346</galeid><sourcerecordid>A534637346</sourcerecordid><originalsourceid>FETCH-LOGICAL-b556t-8275a69d1c5928a62237e4c25a6f31d704270a7f4c13b5de6a1e47e02b0462023</originalsourceid><addsrcrecordid>eNqNUktLxDAQDqL4WL17koIXL13zTteDKIsvWPCi55CmUzfaNrXpCvvvTVldXFCQQB4z3_dl5mMQOiZ4TEgmzwlXNJUTyVLCUo7VFtpfh7Z_3PfQQQivGBOVUbWL9ignhHJJ9tHV1Nct9K53vklck_RzSO6gq02TtHMTT7tMatO9QX-RxBjUreucNVV8mGoZXDhEO6WpAhx9nSP0fHvzNL1PZ493D9PrWZoLIfs0_iuMnBTEignNjKSUKeCWxmDJSKEwpwobVXJLWC4KkIYAV4BpjrmkmLIRulzptou8hsJC03em0m3nYnlL7Y3Tm5nGzfWL_9AsE1LQLApMVwK5838IbGasr_XgoB4c1ITpaHBUOfsqo_PvCwi9rl2wUFWmAb8IkSAmRGCa4f9AM8Ek5zxCT1fQF1OBdk3pYwV2gOtrwbhkathGaPwLKq4Camd9A6WL8Q0CXhFs50PooFx3S7AeBui3_k5-2rwmfE8M-wTOrb5_</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1458536444</pqid></control><display><type>article</type><title>Competition in the German pharmacy market: an empirical analysis</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Springer Nature OA/Free Journals</source><source>PubMed Central Open Access</source><creator>Heinsohn, Jörg G ; Flessa, Steffen</creator><creatorcontrib>Heinsohn, Jörg G ; Flessa, Steffen</creatorcontrib><description>Pharmaceutical products are an important component of expenditure on public health insurance in the Federal Republic of Germany. For years, German policy makers have regulated public pharmacies in order to limit the increase in costs. One reform has followed another, main objective being to increase competition in the pharmacy market. It is generally assumed that an increase in competition would reduce healthcare costs. However, there is a lack of empirical proof of a stronger orientation of German public pharmacies towards competition thus far. This paper analyses the self-perceptions of owners of German public pharmacies and their orientation towards competition in the pharmacy markets. It is based on a cross-sectional survey (N = 289) and distinguishes between successful and less successful pharmacies, the location of the pharmacies (e.g. West German States and East German States) and the gender of the pharmacy owner. The data are analysed descriptively by survey items and employing bivariate and structural equation modelling. The analysis reveals that the majority of owners of public pharmacies in Germany do not currently perceive very strong competitive pressure in the market. However, the innovativeness of the pharmacist is confirmed as most relevant for net revenue development and the profit margin. Some differences occur between regions, e.g. public pharmacies in West Germany have a significantly higher profit margin. This study provides evidence that the German healthcare reforms aimed at increasing the competition between public pharmacies in Germany have not been completely successful. Many owners of public pharmacies disregard instruments of active customer-orientated management (such as customer loyalty or an offensive position and economies of scale), which could give them a competitive advantage. However, it is clear that those pharmacists who strive for systematic and innovative management and adopt an offensive and competitive stance are quite successful. Thus, pharmacists should change their attitude and develop a more professional business model.</description><identifier>ISSN: 1472-6963</identifier><identifier>EISSN: 1472-6963</identifier><identifier>DOI: 10.1186/1472-6963-13-407</identifier><identifier>PMID: 24112461</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Attitudes ; Cross-Sectional Studies ; Economic aspects ; Economic Competition - organization &amp; administration ; Expenditures, Public ; Female ; Financial Management ; Germany ; Health care reform ; Humans ; Male ; Models, Economic ; Pharmaceutical industry ; Pharmacies - economics ; Pharmacies - organization &amp; administration ; Pharmacy ; Surveys and Questionnaires</subject><ispartof>BMC health services research, 2013-10, Vol.13 (1), p.407-407, Article 407</ispartof><rights>COPYRIGHT 2013 BioMed Central Ltd.</rights><rights>Copyright © 2013 Heinsohn and Flessa; licensee BioMed Central Ltd. 2013 Heinsohn and Flessa; licensee BioMed Central Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b556t-8275a69d1c5928a62237e4c25a6f31d704270a7f4c13b5de6a1e47e02b0462023</citedby><cites>FETCH-LOGICAL-b556t-8275a69d1c5928a62237e4c25a6f31d704270a7f4c13b5de6a1e47e02b0462023</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3856528/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3856528/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24112461$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Heinsohn, Jörg G</creatorcontrib><creatorcontrib>Flessa, Steffen</creatorcontrib><title>Competition in the German pharmacy market: an empirical analysis</title><title>BMC health services research</title><addtitle>BMC Health Serv Res</addtitle><description>Pharmaceutical products are an important component of expenditure on public health insurance in the Federal Republic of Germany. For years, German policy makers have regulated public pharmacies in order to limit the increase in costs. One reform has followed another, main objective being to increase competition in the pharmacy market. It is generally assumed that an increase in competition would reduce healthcare costs. However, there is a lack of empirical proof of a stronger orientation of German public pharmacies towards competition thus far. This paper analyses the self-perceptions of owners of German public pharmacies and their orientation towards competition in the pharmacy markets. It is based on a cross-sectional survey (N = 289) and distinguishes between successful and less successful pharmacies, the location of the pharmacies (e.g. West German States and East German States) and the gender of the pharmacy owner. The data are analysed descriptively by survey items and employing bivariate and structural equation modelling. The analysis reveals that the majority of owners of public pharmacies in Germany do not currently perceive very strong competitive pressure in the market. However, the innovativeness of the pharmacist is confirmed as most relevant for net revenue development and the profit margin. Some differences occur between regions, e.g. public pharmacies in West Germany have a significantly higher profit margin. This study provides evidence that the German healthcare reforms aimed at increasing the competition between public pharmacies in Germany have not been completely successful. Many owners of public pharmacies disregard instruments of active customer-orientated management (such as customer loyalty or an offensive position and economies of scale), which could give them a competitive advantage. However, it is clear that those pharmacists who strive for systematic and innovative management and adopt an offensive and competitive stance are quite successful. Thus, pharmacists should change their attitude and develop a more professional business model.</description><subject>Attitudes</subject><subject>Cross-Sectional Studies</subject><subject>Economic aspects</subject><subject>Economic Competition - organization &amp; administration</subject><subject>Expenditures, Public</subject><subject>Female</subject><subject>Financial Management</subject><subject>Germany</subject><subject>Health care reform</subject><subject>Humans</subject><subject>Male</subject><subject>Models, Economic</subject><subject>Pharmaceutical industry</subject><subject>Pharmacies - economics</subject><subject>Pharmacies - organization &amp; administration</subject><subject>Pharmacy</subject><subject>Surveys and Questionnaires</subject><issn>1472-6963</issn><issn>1472-6963</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNUktLxDAQDqL4WL17koIXL13zTteDKIsvWPCi55CmUzfaNrXpCvvvTVldXFCQQB4z3_dl5mMQOiZ4TEgmzwlXNJUTyVLCUo7VFtpfh7Z_3PfQQQivGBOVUbWL9ignhHJJ9tHV1Nct9K53vklck_RzSO6gq02TtHMTT7tMatO9QX-RxBjUreucNVV8mGoZXDhEO6WpAhx9nSP0fHvzNL1PZ493D9PrWZoLIfs0_iuMnBTEignNjKSUKeCWxmDJSKEwpwobVXJLWC4KkIYAV4BpjrmkmLIRulzptou8hsJC03em0m3nYnlL7Y3Tm5nGzfWL_9AsE1LQLApMVwK5838IbGasr_XgoB4c1ITpaHBUOfsqo_PvCwi9rl2wUFWmAb8IkSAmRGCa4f9AM8Ek5zxCT1fQF1OBdk3pYwV2gOtrwbhkathGaPwLKq4Camd9A6WL8Q0CXhFs50PooFx3S7AeBui3_k5-2rwmfE8M-wTOrb5_</recordid><startdate>20131010</startdate><enddate>20131010</enddate><creator>Heinsohn, Jörg G</creator><creator>Flessa, Steffen</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T2</scope><scope>7U2</scope><scope>C1K</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20131010</creationdate><title>Competition in the German pharmacy market: an empirical analysis</title><author>Heinsohn, Jörg G ; Flessa, Steffen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b556t-8275a69d1c5928a62237e4c25a6f31d704270a7f4c13b5de6a1e47e02b0462023</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Attitudes</topic><topic>Cross-Sectional Studies</topic><topic>Economic aspects</topic><topic>Economic Competition - organization &amp; administration</topic><topic>Expenditures, Public</topic><topic>Female</topic><topic>Financial Management</topic><topic>Germany</topic><topic>Health care reform</topic><topic>Humans</topic><topic>Male</topic><topic>Models, Economic</topic><topic>Pharmaceutical industry</topic><topic>Pharmacies - economics</topic><topic>Pharmacies - organization &amp; administration</topic><topic>Pharmacy</topic><topic>Surveys and Questionnaires</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Heinsohn, Jörg G</creatorcontrib><creatorcontrib>Flessa, Steffen</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Safety Science and Risk</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BMC health services research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Heinsohn, Jörg G</au><au>Flessa, Steffen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Competition in the German pharmacy market: an empirical analysis</atitle><jtitle>BMC health services research</jtitle><addtitle>BMC Health Serv Res</addtitle><date>2013-10-10</date><risdate>2013</risdate><volume>13</volume><issue>1</issue><spage>407</spage><epage>407</epage><pages>407-407</pages><artnum>407</artnum><issn>1472-6963</issn><eissn>1472-6963</eissn><abstract>Pharmaceutical products are an important component of expenditure on public health insurance in the Federal Republic of Germany. For years, German policy makers have regulated public pharmacies in order to limit the increase in costs. One reform has followed another, main objective being to increase competition in the pharmacy market. It is generally assumed that an increase in competition would reduce healthcare costs. However, there is a lack of empirical proof of a stronger orientation of German public pharmacies towards competition thus far. This paper analyses the self-perceptions of owners of German public pharmacies and their orientation towards competition in the pharmacy markets. It is based on a cross-sectional survey (N = 289) and distinguishes between successful and less successful pharmacies, the location of the pharmacies (e.g. West German States and East German States) and the gender of the pharmacy owner. The data are analysed descriptively by survey items and employing bivariate and structural equation modelling. The analysis reveals that the majority of owners of public pharmacies in Germany do not currently perceive very strong competitive pressure in the market. However, the innovativeness of the pharmacist is confirmed as most relevant for net revenue development and the profit margin. Some differences occur between regions, e.g. public pharmacies in West Germany have a significantly higher profit margin. This study provides evidence that the German healthcare reforms aimed at increasing the competition between public pharmacies in Germany have not been completely successful. Many owners of public pharmacies disregard instruments of active customer-orientated management (such as customer loyalty or an offensive position and economies of scale), which could give them a competitive advantage. However, it is clear that those pharmacists who strive for systematic and innovative management and adopt an offensive and competitive stance are quite successful. Thus, pharmacists should change their attitude and develop a more professional business model.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>24112461</pmid><doi>10.1186/1472-6963-13-407</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1472-6963
ispartof BMC health services research, 2013-10, Vol.13 (1), p.407-407, Article 407
issn 1472-6963
1472-6963
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3856528
source MEDLINE; Springer Nature - Complete Springer Journals; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Springer Nature OA/Free Journals; PubMed Central Open Access
subjects Attitudes
Cross-Sectional Studies
Economic aspects
Economic Competition - organization & administration
Expenditures, Public
Female
Financial Management
Germany
Health care reform
Humans
Male
Models, Economic
Pharmaceutical industry
Pharmacies - economics
Pharmacies - organization & administration
Pharmacy
Surveys and Questionnaires
title Competition in the German pharmacy market: an empirical analysis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T01%3A50%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Competition%20in%20the%20German%20pharmacy%20market:%20an%20empirical%20analysis&rft.jtitle=BMC%20health%20services%20research&rft.au=Heinsohn,%20J%C3%B6rg%20G&rft.date=2013-10-10&rft.volume=13&rft.issue=1&rft.spage=407&rft.epage=407&rft.pages=407-407&rft.artnum=407&rft.issn=1472-6963&rft.eissn=1472-6963&rft_id=info:doi/10.1186/1472-6963-13-407&rft_dat=%3Cgale_pubme%3EA534637346%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1458536444&rft_id=info:pmid/24112461&rft_galeid=A534637346&rfr_iscdi=true